NSTK · 01.2026Independent supplement reference
NutriStack
Edition 1.0Updated August 1, 2026

Supplement × Prescription·Evidence index

Fenofibrate and Milk Thistle: what the published research says

PubMed indexes 4 records that name Fenofibrate and Milk Thistle together, either in the title or in an interaction, co-administration, or pharmacokinetic context. Each one is listed below with its study design and, where the abstract states one, the authors’ own conclusion, quoted and linked. This page reports that literature. It does not tell you whether to combine them.

Read this first

An evidence index, not guidance.

Every statement below is attributed to a named, dated, linked source.

This page lists published research relevant to Fenofibrate and Milk Thistle. It deliberately does not state whether the combination is safe, whether it interacts, in which direction, at what dose, or how far apart to take them.

The research

4 studies naming Fenofibrate and Milk Thistle.

Strongest relevance first: papers naming both substances in the title, then human trials and systematic reviews.

COMPARATIVE ASSESSMENT OF THE EFFECT OF SILYMARIN, FENOFIBRATE, BETAINE AND ADEMETIONINE ON THE DEVELOPMENT OF STEATOHEPATITIS IN WISTAR RATS.

Georgian medical news · 2025 · PMID 41314208

Comparative StudyAnimal study

“Fenofibrate was the most effective agent in preventing fructose-induced hepatic steatosis and transaminase elevation, in line with activation of PPAR-α-dependent β-oxidation and inhibition of lipogenesis.”

Zozulya et al. · Authors' conclusion

Names both Fenofibrate and Milk Thistle in its title.

Targeting metabolic dysfunction-associated steatotic liver disease with phytosomal silymarin and piperine: A natural alternative to fenofibrate in a rat model.

Naunyn-Schmiedeberg's archives of pharmacology · 2026 · PMID 41196338

Animal study

“This study demonstrates the potential of a phytosomal silymarin-piperine-lecithin complex as a natural therapeutic avenue for MASLD, outperforming a conventional lipid-lowering agent in this animal model. Future clinical and pharmacokinetic studies are warranted.”

Tawfik et al. · From the abstract

Names both Fenofibrate and Milk Thistle in its title.

Beneficial Effect of Fenofibrate and Silymarin on Hepatic Steatosis and Gene Expression of Lipogenic and Cytochrome P450 Enzymes in Non-Obese Hereditary Hypertriglyceridemic Rats.

Current issues in molecular biology · 2022 · PMID 35678658

“In addition, fenofibrate-induced increased CYP4A1 expression was decreased, suggesting a reduction in the pro-inflammatory effects of fenofibrate. These results show high efficacy and mechanisms of action of the combination of fenofibrate with silymarin in treating hepatic steatosis and indicate the possibility of protection against disorders in which oxidative stress and inflammation are involved.”

Vecera et al. · From the abstract

Names both Fenofibrate and Milk Thistle in its title.

Limitations

What this evidence cannot tell you.

Search-based evidence indexes have real limits, and it is worth being explicit about them:

NutriStack

Track what you actually take.

NutriStack is a free iPhone app for organising a supplement routine: what you take, when, and what the published record says about it. Its exploratory interaction checker covers Fenofibrate, Milk Thistle, and several hundred other substances.

The checker is a research and organisation tool, not a clinical decision aid, and its per-pair assessments are excluded from search until they pass claim-level review.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.